EURAP outcomes for seizure control during pregnancy: useful and encouraging data

Comment

Page B Pennell. Epilepsy Curr. 2006 Nov-Dec.

. 2006 Nov-Dec;6(6):186-8.

doi: 10.1111/j.1535-7511.2006.00140.x.

No abstract available

Comment on

Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry.
EURAP Study Group. EURAP Study Group. Neurology. 2006 Feb 14;66(3):354-60. doi: 10.1212/01.wnl.0000195888.51845.80. Epub 2005 Dec 28. Neurology. 2006. PMID: 16382034

1. Say L, Donner A, Gulmezoglu AM, Taljaard M, Piaggio G. The prevalence of stillbirths: A systematic review. Reprod Health. 2006;3:1–11. - PMC - PubMed
1. Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology. 2003;61(6 suppl 2):S35–S42. - PubMed
1. Pennell PB, Newport DJ, Stowe ZN, Helmers SL, Montgomery JQ, Henry TR. The impact of pregnancy and childbirth on the metabolism of lamotrigine. Neurology. 2004;62:292–295. - PubMed
1. Holmes LB, Wyszynski DF, Baldwin EJ, Habecker E, Glassman LH, Smith CR. Increased risk for non-syndromic cleft palate among infants exposed to lamotrigine during pregancy. Birth Defects Res (Part A): Clin Mol Teratol. 2006;76:5.
1. Meador KJ, Baker GA, Finnell RH, Kalayjian LA, Liporace JD, Loring DW, Mawer G, Pennell PB, Smith JC, Wolff MC, NEAD Study Group In utero antiepileptic drug exposure: Fetal death and malformations. Neurology. 2006;67:407–412. - PMC - PubMed